Danielle Marchell
@dmarchell.bsky.social
Head of PR at Equip. Californian turned Texan with a passion for pop culture and a good cup of coffee.
🚨 New research: #BMI shouldn’t decide who gets eating disorder treatment. Equip's study found AAN & AN have nearly identical risks—but people w/ AAN are often denied care for not being “underweight.” With EDs at an all-time high, it’s time to rethink standards: journals.plos.org/plosone/arti...
Comparison of clinical presentation and treatment response among youth with atypical anorexia nervosa and anorexia nervosa
Objective Atypical anorexia nervosa (AAN) is an eating disorder that shares all symptoms with anorexia nervosa (AN) except “significantly low weight.” Here, we aim to further understand the potential ...
journals.plos.org
March 7, 2025 at 4:30 PM
🚨 New research: #BMI shouldn’t decide who gets eating disorder treatment. Equip's study found AAN & AN have nearly identical risks—but people w/ AAN are often denied care for not being “underweight.” With EDs at an all-time high, it’s time to rethink standards: journals.plos.org/plosone/arti...
Big day at Equip; @kerrywashington.bsky.social has joined us as an advisor+investor to help us achieve our mission of providing eating disorder treatment to anyone who needs it. Thanks to @emmahinchliffe.bsky.social and @fortune.com for breaking the news! fortune.com/2025/02/20/k...
Kerry Washington joins eating disorder startup Equip
The "Scandal" star is joining the eating disorder treatment startup Equip Health as an investor and adviser.
fortune.com
February 20, 2025 at 7:08 PM
Big day at Equip; @kerrywashington.bsky.social has joined us as an advisor+investor to help us achieve our mission of providing eating disorder treatment to anyone who needs it. Thanks to @emmahinchliffe.bsky.social and @fortune.com for breaking the news! fortune.com/2025/02/20/k...
Jazzed to help with this @nbcnews.com story on the impact that restricting gender-affirming care will have for trans youth battling eating disorders. Gender-affirming care IS eating disorder care: www.nbcnews.com/nbc-out/out-...
Bans on transgender care for minors may complicate eating disorder treatment
For many trans people with eating disorders, gender-affirming care offers the best way to relieve the distress that drives them to starve themselves.
www.nbcnews.com
January 7, 2025 at 11:50 PM
Jazzed to help with this @nbcnews.com story on the impact that restricting gender-affirming care will have for trans youth battling eating disorders. Gender-affirming care IS eating disorder care: www.nbcnews.com/nbc-out/out-...
Fascinating read in Men's Health on "bigorexia" and Gen Z. Just a reminder: diet culture isn’t unique to only women. www.menshealth.com/health/a6283...
Gen Z’s Dangerous Quest for Gains
Thanks to social media saturation and crafty supplement marketing, young boys are pushing weights and chugging shakes to get strong. The dangers—physical and mental—are real.
www.menshealth.com
December 6, 2024 at 5:23 PM
Fascinating read in Men's Health on "bigorexia" and Gen Z. Just a reminder: diet culture isn’t unique to only women. www.menshealth.com/health/a6283...
Major stat from this 💔 WSJ piece: www.wsj.com/health/pharm...
"More than 30,000 adolescents between the ages of 12 and 17 were dispensed brand name and compounded GLP-1 medications last year, according to an analysis by University of Michigan researchers. Of that group, 60% were female."
"More than 30,000 adolescents between the ages of 12 and 17 were dispensed brand name and compounded GLP-1 medications last year, according to an analysis by University of Michigan researchers. Of that group, 60% were female."
A 12-Year-Old’s Journey Into the World of Ozempic
A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy a...
www.wsj.com
November 26, 2024 at 2:09 AM
Major stat from this 💔 WSJ piece: www.wsj.com/health/pharm...
"More than 30,000 adolescents between the ages of 12 and 17 were dispensed brand name and compounded GLP-1 medications last year, according to an analysis by University of Michigan researchers. Of that group, 60% were female."
"More than 30,000 adolescents between the ages of 12 and 17 were dispensed brand name and compounded GLP-1 medications last year, according to an analysis by University of Michigan researchers. Of that group, 60% were female."